Having trouble viewing this email? View in your browser.
ESCMID Logo

16 July 2019
WEEKLY NEWS

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,

ESCMID Executive Office.

 

ESCMID / European Respiratory Society (ERS) collaboration

ESCMID offers our colleagues that are ERS members a 15% discount on the price of ESCMID membership (the discount is not applicable on fees for printed journals). Don’t miss this opportunity! Click here to find out more.

› Read more

ESCMID Study Group Research Grants: the call will close soon!

ESCMID Study Groups are the core of our Society. Through them, ESCMID actively enriches the scientific community with new findings, which results in scientific publications, including medical guidelines and textbooks. Also for 2019, ESCMID will support Study Group research projects in the fields of clinical microbiology and infectious diseases. The call to apply for the ESCMID Study Group Research Grants officially opened 17 May 2019 and the deadline for submitting your applications is 17 July 2019, 17:00 CEST. All information regarding ESCMID Study Group Research funding is available herePlease carefully read the updated “What you need to apply” section: important changes have been made compared to the previous call.

› Read more

Only 30 seats left for IMMEM XII in Dubrovnik

Don’t miss your chance to enroll in the upcoming 12th International Meeting on Microbial Epidemiological Markers (IMMEM XII) in Dubrovnik this September!

The theme of this meeting is “Moving towards genome-based pathogen surveillance – lessons learnt and challenges ahead”.

Find out more on the conference website.

› Read more
 

GARDP Websymposium - Enabling academia to fill the discovery gap - Learnings from industry and funders

Don’t miss another exciting websymposium, this time an encore of a Meet-the-expert session from ASM Microbe 2019. Join speaker Ursula Theuretzbacher and Moderator Laura Piddock  this Thursday, 18 July between 9:00-10:30am CEST.Find out more and sign up at the GARDP Website.

› Read more
 

Second ESCMID Course on Precision Medicine (26 – 28 September 2019, Rome, Italy): register now!

Precision medicine has become a key-stone to improve the patient’s management and increase recovery rates. The Second ESCMID Course on Precision Medicine will take place in Roma, Italy, next September. Don`t miss the opportunity to participate!
 
Upon completion of this course, participants will be able to:

• Understand the pharmacokinetic and epidemiologic heterogeneity in patient populations traditionally excluded from clinical studies such as the critically ill; the elderly; those with renal insufficiency; the obese; and female patients.
• Understand the evidence (or lack thereof) for medical decision-making in these populations.
• Explore both the limits and the strengths of current “one-size-fits-all” guidelines.
• Understand the clinical implications of variations in local epidemiology, microbiota, and regional perceptions regarding antimicrobial use.
• Explore the clinical evidence for recommended durations of antimicrobial therapy.
• Understand the variation in pharmacokinetics across populations.

Please click here to complete your registration! 

› Read more
 

CMI highlight: Clostridioides difficile contamination in the environment of a clinical microbiology laboratory and laboratory workers

E. Reigadas et al, objective was to assess environmental contamination by C. difficile and its potential for transmission in a clinical microbiology laboratory.

Clostridioides difficile infection (CDI) has traditionally considered to be transmitted predominantly within healthcare settings. C. difficile is not recognized as a pathogen that presents a risk of laboratory acquisition. Data on laboratory contamination and acquisition by laboratory personnel are lacking.

Laboratory surfaces were screened for C. difficile. Samples were taken in areas that handle C. difficile isolates (high-exposure [HE] areas), areas adjacent to HE areas or those processing fecal samples (medium exposure [ME] areas), and areas that do not process fecal samples or C. difficile isolates (low exposure [LE] areas). The authors examined C. difficile carriage (hands/rectal samples) of laboratory workers.

A total of 140 environmental samples were collected from two HE areas (n = 56), two ME areas (n=56), and two LE areas (n = 28). Overall, 37.8% (37/98) of surfaces were contaminated with C. difficile, and 17.3% (17/98) with toxigenic C. difficile (TCD). HE areas were significantly more contaminated with TCD than LE areas (38.1% [16/42] vs 0.0% [0/14], p=0.005) and ME areas (38.1% [16/42] vs 2.4% [1/42], p<0.001). Hands were colonized with TCD in 11.8% (4/34) of cases. The authors found no rectal carriage of C. difficile.

E. Reigadas et al, found a significant proportion of laboratory surfaces to be contaminated with toxigenic C. difficile, as well as hand colonization of laboratory personnel. The recommend specific control measures for high-risk areas and laboratory personnel working in these areas.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.